About
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 705 investors are based in Melbourne, Victoria, Australia.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Melbourne, Australia
Contact Information
Find more investors like Telix
Search Investors